Comparison

Alpha-Synuclein Aggregation Assay Kit

Item no. CSR-SYN01
Manufacturer Cosmobio
Amount 1 Kit
Category
Type Kit
Specific against other
ECLASS 10.1 32161090
ECLASS 11.0 32161090
UNSPSC 41116126
Available
Manufacturer - Category
Research Area/Neurobiology/Neurodegeneration/Kits; Research Area/Organs & Organ Systems/Brain/Kits; Research Area/Disease/Parkinson Disease/Kits; Research Area/Disease/Lewy Body Dementia/Kits; Research Area/Disease/Multiple System Atrophy/Kits; Assays/Neurobiology/Kits; Cells & Cell Culture/Kits/Neurobiology; Assays/Kits/Neurobiology
Maker
CSR
Short Description
Contains all key reagents needed to promote the formation of aggregates in cultured cells resembling patient aggregates; by the seeded aggregation technique of Nonaka et. al (2010). Sufficient for 400 tests.
Description

Product Summary
Dementia is a disease that causes memory and judgement loss, there is no fundamental treatment developed for it.
Years of scientific research has proven that protein aggregation occurs in the degeneration part of the brain for many
neurodegenerative diseases including dementia, indicating appearance of this aggregation is closely related to these diseases
development and progression.
Aggregation occurs when normal protein forms abnormal structure for particular reasons and accumulates in the cell, which
each disease has different aggregating protein. It is known that protein called “ α -Synuclein“ forms abnormal structure in Parkinson Disease / Lewy Body Dementia / Multiple system atrophy patient brain.
α -Synuclein Aggregation Assay Kit mimics intracellular aggregation of “ α -Synuclein“, which allows in vitro screening of
active ingredients.
Amyloid protein aggregates in brain neruonal and glial cells are a hallmark of several human neurodegenerative diseases. In Parkinson disease and dementia with Lewy bodies patients, for example, fibrilar a-synuclein protein is the major aggregate component and it is believed that these aggregates are related to disease etiology.
Overexpression of a-synuclein in cells by plasmid transfection alone does not result in a-synuclein aggregation. However, as described by Nonaka et. al. (1) co-transfection of plasmid with preformed a-synuclein protein fibrils into SH-SY5Y (neuroblastoma-derived) cells results in the rapid formation of phosphorylated, ubiquitinated and partially thyoflavin positive a-syn fibrilar aggregates that are mophologically and physicochemically similar to those in patient brain.
This kit contains all critical reagents needed to peform the seeded aggregation technique of Nonoka et al in your lab, with the cells of your choice, enabling a-synuclein aggregate formation to be studied kinetically, structurally, pathologically, or in response to biological and chemical manipulation.
(1) Nonaka T, Watanabe ST, Iwatsubo T, Hasegawa M. Seeded aggregation and toxicity of {alpha}-synuclein and tau: cellular models of neurodegenerative diseases. J Biol Chem. 2010 Nov 5; 285(45):34885-98. doi: 10.1074/jbc.M110.148460. Epub 2010 Aug 30. PMID: 20805224; PMCID: PMC2966103.




Kit Components

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 1 Kit
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close